Nectar Lifesciences
NECLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Sanjiv Goyal · MD: Sanjiv Goyal · Listing date: July 19, 2005 · Employees: 1693 · Chandigarh · http://www.neclife.com

Stock Price vs Company Growth
1d
0.3%
1w
0.8%
1m
0.4%
3m
43.0%
6m
39.4%
1y
32.9%
5y
9.0%
10y
4.5%
all
2.2%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec10Jun14Dec17Jun21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

22.8 0.3%
21.1
40
Company Overview

Sales
1,684 Cr
Growth: 2.3%
Profit after Tax
17 Cr
Growth: 58.5%
Small Cap
512 Cr
P/E: 30.0x
Industry P/E: 30.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 1,684
Growth 2.3%
EBITDA 10.5%
P/S 0.3x
Dividend 0.0%
P/E 30.0x
Book Value ₹ 1
PEG Ratio 13.3x
ROE 75.8%
P/B N/A
Shareholding Pattern

Institutions
Nsr Direct Pe Mauritius Llc
14.59 %
Ingain Traders, Llc
1.34 %
Iepf
0.02 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Jun21Sep21Sep22
Promoters
Sanjiv Goyal
31.33 %
Sanjiv (Huf)
24.47 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Jun21Sep21Sep22
Others
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Jun21Sep21Sep22
Increase    Decrease    No change
Company Profile Detailed

The company has developed fully integrated sustainable production systems to manufacture high quality Cephalosporin intermediates, - Active Pharmaceuticals ingredients (APIs) and Finished Dosage Formulations (FDF or Formulations) to meet the diverse requirements of its customer base in India and over many countries worldwide.
Investors (26)
Followers (2)